Safety and efficacy of nab-paclitaxel (nab-P)-based therapy in patients (pts) with non-small cell lung cancer (NSCLC) and performance status (PS) 2: Results from ABOUND.PS2. Article

Full Text via DOI: 10.1200/JCO.2017.35.15_suppl.9058 Web of Science: 000411932202118
Industry Collaboration

Cited authors

  • Gajra, Ajeet; Karim, Nagla Abdel; Mulford, Deborah A.; Villaruz, Liza Cosca; Matrana, Marc Ryan; Ali, Haythem Y.; Santos, Edgardo S.; Ong, Teng Jin; Sanford, Alexandra; Amiri, Katayoun; Spigel, David R.

Publication date

  • 2017

Published in

International Standard Serial Number (ISSN)

  • 0732-183X


  • 35